23,100 Shares in Align Technology, Inc. $ALGN Purchased by Militia Capital Partners LP

Militia Capital Partners LP acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 23,100 shares of the medical equipment provider’s stock, valued at approximately $3,670,000. Align Technology accounts for approximately 2.9% of Militia Capital Partners LP’s portfolio, making the stock its 9th biggest holding.

Other institutional investors have also recently bought and sold shares of the company. Teacher Retirement System of Texas acquired a new stake in Align Technology during the 1st quarter worth about $1,647,000. Asset Management One Co. Ltd. boosted its position in Align Technology by 14.5% during the 1st quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after acquiring an additional 4,009 shares during the period. American Assets Inc. acquired a new stake in Align Technology during the 4th quarter worth about $417,000. Janney Montgomery Scott LLC boosted its position in Align Technology by 48.9% during the 1st quarter. Janney Montgomery Scott LLC now owns 10,120 shares of the medical equipment provider’s stock worth $1,608,000 after acquiring an additional 3,325 shares during the period. Finally, Wealth Enhancement Advisory Services LLC boosted its position in Align Technology by 44.3% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,380 shares of the medical equipment provider’s stock worth $1,490,000 after acquiring an additional 2,881 shares during the period. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Stock Performance

ALGN opened at $135.91 on Friday. The business has a 50 day moving average price of $161.93 and a 200 day moving average price of $170.56. Align Technology, Inc. has a twelve month low of $127.70 and a twelve month high of $262.87. The firm has a market cap of $9.85 billion, a P/E ratio of 22.92, a price-to-earnings-growth ratio of 1.50 and a beta of 1.65.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the firm posted $2.41 earnings per share. The firm’s revenue for the quarter was down 1.6% compared to the same quarter last year. Align Technology has set its Q3 2025 guidance at EPS. As a group, analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its board has authorized a stock buyback plan on Tuesday, August 5th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other Align Technology news, CEO Joseph M. Hogan purchased 7,576 shares of the business’s stock in a transaction dated Friday, August 1st. The stock was bought at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the acquisition, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Stifel Nicolaus decreased their price objective on Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research report on Thursday, July 31st. Mizuho set a $210.00 price objective on Align Technology in a research report on Thursday, July 31st. Evercore ISI lifted their price target on Align Technology from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Wednesday, July 9th. Wells Fargo & Company reduced their price target on Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a report on Thursday, July 31st. Finally, Zacks Research lowered Align Technology from a “hold” rating to a “strong sell” rating in a report on Monday, September 1st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $215.00.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.